Cargando…

Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection

BACKGROUND: Antibody-mediated rejection (AMR) remains one of the major barriers for graft survival after kidney transplantation. Our previous study suggested a gut microbiota dysbiosis in kidney transplantation recipients with AMR. However, alternations in gut microbial function and structure at spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Li, Ruoying, Ji, Bingqing, Zhao, Lili, Wang, Junpeng, Yan, Tianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784291/
https://www.ncbi.nlm.nih.gov/pubmed/36564805
http://dx.doi.org/10.1186/s12967-022-03825-6
_version_ 1784857775275245568
author Li, Xin
Li, Ruoying
Ji, Bingqing
Zhao, Lili
Wang, Junpeng
Yan, Tianzhong
author_facet Li, Xin
Li, Ruoying
Ji, Bingqing
Zhao, Lili
Wang, Junpeng
Yan, Tianzhong
author_sort Li, Xin
collection PubMed
description BACKGROUND: Antibody-mediated rejection (AMR) remains one of the major barriers for graft survival after kidney transplantation. Our previous study suggested a gut microbiota dysbiosis in kidney transplantation recipients with AMR. However, alternations in gut microbial function and structure at species level have not been identified. In the present study, we investigated the metagenomic and metabolic patterns of gut microbiota in AMR patients to provide a comprehensive and in-depth understanding of gut microbiota dysbiosis in AMR. METHODS: We enrolled 60 kidney transplantation recipients, 28 showed AMR and 32 were non-AMR controls with stable post-transplant renal functions. Shotgun sequencing and untargeted LC/MS metabolomic profiling of fecal samples were performed in kidney transplantation recipients with AMR and controls. RESULTS: Totally, we identified 311 down-regulated and 27 up-regulated gut microbial species associated with AMR after kidney transplantation, resulting in the altered expression levels of 437 genes enriched in 22 pathways, of which 13 were related to metabolism. Moreover, 32 differential fecal metabolites were found in recipients with AMR. Among them, alterations in 3b-hydroxy-5-cholenoic acid, l-pipecolic acid, taurocholate, and 6k-PGF1alpha-d4 directly correlated with changes in gut microbial species and functions. Specific differential fecal species and metabolites were strongly associated with clinical indexes (Cr, BUN, etc.), and could distinguish the recipients with AMR from controls as potential biomarkers. CONCLUSIONS: Altogether, our findings provided a comprehensive and in-depth understanding of the correlation between AMR and gut microbiota, which is important for the etiological and diagnostic study of AMR after kidney transplantation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03825-6.
format Online
Article
Text
id pubmed-9784291
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97842912022-12-24 Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection Li, Xin Li, Ruoying Ji, Bingqing Zhao, Lili Wang, Junpeng Yan, Tianzhong J Transl Med Research BACKGROUND: Antibody-mediated rejection (AMR) remains one of the major barriers for graft survival after kidney transplantation. Our previous study suggested a gut microbiota dysbiosis in kidney transplantation recipients with AMR. However, alternations in gut microbial function and structure at species level have not been identified. In the present study, we investigated the metagenomic and metabolic patterns of gut microbiota in AMR patients to provide a comprehensive and in-depth understanding of gut microbiota dysbiosis in AMR. METHODS: We enrolled 60 kidney transplantation recipients, 28 showed AMR and 32 were non-AMR controls with stable post-transplant renal functions. Shotgun sequencing and untargeted LC/MS metabolomic profiling of fecal samples were performed in kidney transplantation recipients with AMR and controls. RESULTS: Totally, we identified 311 down-regulated and 27 up-regulated gut microbial species associated with AMR after kidney transplantation, resulting in the altered expression levels of 437 genes enriched in 22 pathways, of which 13 were related to metabolism. Moreover, 32 differential fecal metabolites were found in recipients with AMR. Among them, alterations in 3b-hydroxy-5-cholenoic acid, l-pipecolic acid, taurocholate, and 6k-PGF1alpha-d4 directly correlated with changes in gut microbial species and functions. Specific differential fecal species and metabolites were strongly associated with clinical indexes (Cr, BUN, etc.), and could distinguish the recipients with AMR from controls as potential biomarkers. CONCLUSIONS: Altogether, our findings provided a comprehensive and in-depth understanding of the correlation between AMR and gut microbiota, which is important for the etiological and diagnostic study of AMR after kidney transplantation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03825-6. BioMed Central 2022-12-23 /pmc/articles/PMC9784291/ /pubmed/36564805 http://dx.doi.org/10.1186/s12967-022-03825-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Xin
Li, Ruoying
Ji, Bingqing
Zhao, Lili
Wang, Junpeng
Yan, Tianzhong
Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title_full Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title_fullStr Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title_full_unstemmed Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title_short Integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
title_sort integrative metagenomic and metabolomic analyses reveal the role of gut microbiota in antibody-mediated renal allograft rejection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784291/
https://www.ncbi.nlm.nih.gov/pubmed/36564805
http://dx.doi.org/10.1186/s12967-022-03825-6
work_keys_str_mv AT lixin integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection
AT liruoying integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection
AT jibingqing integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection
AT zhaolili integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection
AT wangjunpeng integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection
AT yantianzhong integrativemetagenomicandmetabolomicanalysesrevealtheroleofgutmicrobiotainantibodymediatedrenalallograftrejection